Welcome to the I-SPY 2 Trial

Play Video

The I-SPY 2 Trial is an investigational drug trial for newly diagnosed patients with locally advanced breast cancer. An investigational drug has been approved for testing in people by the U.S. Food and Drug Administration (FDA) but has not yet been approved for widespread use. A clinical trial tests how well investigational drugs work and whether they are safe to use.

The I-SPY 2 Trial has three main phases

Screening, Treatment and Follow Up

Contact Us
Investigators Portal
QLHC in the News
Working at QL
Contact Us